Ashley Shoemaker

February 10, 2022

New insights into hypothalamic obesity

A common Type 2 diabetes treatment being tested for hypothalamic obesity had unexpected results on weight loss and total energy expenditure, Vanderbilt researchers report.

By VUMC News and Communications
November 3, 2020

New treatment for a rare obesity

Diabetes drugs known as GLP-1 receptor agonists, such as exenatide (Byetta), are a promising and safe treatment for a rare form of obesity.

By Bill Snyder
November 14, 2019

VUMC researchers set for Cutting-Edge Discovery Lecture

Antiviral immunity, obesity and pulmonary fibrosis will be discussed by three Vanderbilt University researchers during a Cutting-Edge Discovery Lecture on Nov. 21. The lecture will begin at 4 p.m. in 208 Light Hall.

By Leigh MacMillan
August 9, 2018

Kropski, Shoemaker honored by Doris Duke Foundation

Two early-career physician-scientists at Vanderbilt University Medical Center are among 18 recipients of 2018 Clinical Scientist Development Awards announced July 31 by the Doris Duke Charitable Foundation.

By Bill Snyder
February 13, 2018

Cognition in rare hormonal disorder

Vanderbilt investigators have conducted the first systematic evaluation of cognitive function in children with a rare genetic disorder.

By Leigh MacMillan
June 22, 2017

Vanderbilt Pre-Diabetes Clinic tackles type 2 diabetes in children

In Middle Tennessee, where roughly one-third of children are overweight or obese, the risk of developing pediatric type 2 diabetes is high and the consequences can be serious.

By VUMC News and Communications